ArticleBioactive materials2026
Composite hydrogel-microsphere delivery system promotes early nerve-mediated bone regeneration and late-stage mechanotransduction-driven bone remodeling via sequential release of NGF and Yoda1.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Stimulation Based Drug Release From Dual-Layered Microspheres.Macromolecular bioscience · 2026Article
- Piezo1 channel: structure, mechanogating mechanism, functions, diseases and therapeutic strategy.Molecular biomedicine · 2026Review
- Temporal-responsive hydrogels reprogramming energy metabolic pathway in the bone-angiogenic cascade for diabetic bone regeneration.Materials today. Bio · 2026Article
- CGRP-empowered stem cell sheet/short nanofiber spongeMaterials today. Bio · 2026Article
- Sympathetic regulation of bone homeostasis and remodeling: molecular mechanisms, pathophysiological roles, and therapeutic implications.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuromodulatory signals play a critical role in initiating early vascularized bone regeneration following bone injury. Despite advancements in bone tissue engineering centered on mesenchymal stem cell regulation, the pivotal contributions of early innervation and late mechanical transduction in bone regeneration and remodeling are frequently overlooked. Nerve growth factor (NGF) facilitates neuronal axon regeneration in the initial stage of bone injury, while Yoda1, acting as a chemical agonist, triggers Piezo1-mediated mechanical transduction signals crucial for the mid-to-late stages of bone remodeling. This study developed a composite sequential delivery system utilizing GelMA hydrogel and PLA microspheres to enable the rapid release of NGF and delayed release of Yoda1, mimicking and expediting the natural bone repair process. The system was found to stimulate the migration and maturation of RSC96 and induce neuronal-like differentiation of PC-12, subsequently enhancing osteogenesis and angiogenesis within a neuromodulatory microenvironment. Notably, early neurovascularization and collagen fiber deposition were observed in a subcutaneous implantation model. Further investigations in a femur defect model confirmed that the rapid release of NGF initiates early neuro-vascular-osteogenic coupling, while sustained Yoda1 release in the mid-to-late phases activates and maintains bone regeneration and remodeling effects. In summary, this study underscores the critical roles of early innervation and late-stage mechanical transduction in bone regeneration, offering an innovative and precise therapeutic approach for bone defects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.